Page Tools
What's New
- 2008: A Bad Year for the GM Multinationals
- A Europe by the people for the people
- Comment on the G-20 Declaration on "Financial Markets and the World Economy"
- The medical profession has been wrong before
- Oil and Drug Cartel Plans "Global Coup" through IMF
- Stop the AIDS Genocide of the Drug Cartel
- Recognise the signs of the times! Reputable cancer research journal invites Dr. Rath to be a reviewer – and then retracts…
- Why Nutrient Supplementation Is Important in Heart Failure and Arrhythmia
Aids ResearchVitamin B12 malabsorption in patients with acquired immunodeficiency syndrome.Archives of internal medicine; VOL: 149 (9); p. 2039-41 Harriman GR; Smith PD; Horne MK; Fox CH; Koenig S; Lack EE; Lane HC; Fauci AS We have examined 11 patients with the acquired immunodeficiency syndrome (AIDS) for evidence of subclinical vitamin B12 malabsorption. Three subjects (27%) had low levels of vitamin B12. Eight subjects (73%), including these 3 subjects plus 5 others with normal vitamin B12 levels, had abnormal Schilling test results. In addition, 15% of an unselected population of 121 patients with AIDS and 7% of 27 patients without AIDS who were seropositive for human immunodeficiency virus type 1 (HIV-1) had low serum vitamin B12 levels. Stool cultures from the 8 subjects with abnormal Schilling test results revealed no pathogens. Intestinal involvement by Kaposi's sarcoma was found in only 1 patient. Biopsy specimens from 5 of 6 patients with vitamin B12 malabsorption, however, contained mononuclear cells harboring HIV-1, as indicated by in situ hybridization studies. Our observations suggest that vitamin B12 malabsorption is common in patients with AIDS and may be a very early manifestation of infection with HIV-1. |